Manufacturer record
Athens Life Sciences: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
21 batches manufactured by Athens Life Sciences (Himachal Pradesh) were declared Not of Standard Quality between May 2019 and June 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
21 records linked to Athens Life Sciences in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Povidone-Iodine & Metronidazole Ointment | 25343AMfg 2025-08 · Exp 2027-07 | ContentOther | DTL, Madurai-19State lab | Jun 2026 |
| Pantoprazole Gastro-resistant Tablets IP | TG25-03290Mfg 2025-02 · Exp 2027-01 | The sample does not comply as per I.P. 2022 with respect to the test for Dissolution in Acid Stage for Pantoprazole and Description.Dissolution | RDTL, GuwahatiCDSCO lab | Jun 2026 |
| Cefipodoxime Tablets IP 200mg | TCS25-0238AMfg 2025-08 · Exp 2027-07 | DissolutionDissolution | RDTL, Bellary, KarnatakaState lab | May 2026 |
| Rabeprazole Gastro-resistant Tablets IP | TG24-14255Mfg 2024-06 · Exp 2026-05 | Content of Rabeprazole SodiumOther | SDT&RL, BhubaneswarState lab | Mar 2026 |
| Ondansetron Orally Disintegrating Tablets IP 8mg | TG24-0742Mfg 2024-04 · Exp 2026-03 | Assay, Disintegration & Dissolution.Assay | DTL, JaipurState lab | Mar 2026 |
| Ambroxol Hydrochloride, Levosalbutamol & Guaiphenesin Syrup | LG24-0413Mfg 2024-03 · Exp 2026-02 | The sample does not conform to Manufacturer's specification with respect to tests of Assay of Levosalbutamol and Ambroxol Hydrochloride.Assay | CDL, KolkataCDSCO lab | Feb 2026 |
| Pantoprazole Gastro Resistant Tablets IP | TG25-1814AMfg 2025-10 · Exp 2027-09 | Failed Disintegration and Uniformity of weightDisintegration | DTL, PuducherryState lab | Jan 2026 |
| Rabeprazole Gastro-resistant Tablets IP (RABIMIST-20) | TG24-1514EMfg 2024-07 · Exp 2026-06 | Test for Dissolution and AssayAssay | DTL, Bengaluru, KarnatakaState lab | Oct 2025 |
| Rabeprazole Sodium (EC) & Domperidone (SR) Capsules (Sesarab-DSR Capsules ) | CG23-0372FMfg 2023-09 · Exp 2025-08 | Assay of Rabeprazole SodiumAssay | CDL KolkataCDSCO lab | Jun 2025 |
| Graficlav 625 Tablets (Amoxycillin & Potassium Clavulanate Tablets IP) | TB24-0753AMfg 2024-11 · Exp 2026-04 | Uniformity of Weight of TabletsUniformity of weight/content | State Lab KarnatakaState lab | Jun 2025 |
| Pantoprazole Gastro Resistant Tablets IP (PANCID ? 40) | TG24- 1031CMfg 2024-05 · Exp 2026-04 | DissolutionDissolution | SDTL Agartala, TripuraState lab | Nov 2024 |
| Laxnorm Solution (Lactulose Solution USP) | LG24-0204Mfg 2024-02 · Exp 2026-01 | AssayAssay | CDL KolkataCDSCO lab | Aug 2024 |
| KOOCAL-500 Tablets (Calcium with Vitamin D Tablets IP) | TG21-2330Mfg 2021-09 · Exp 2023-02 | Assay of Vitamin D3Assay | RDTL GuwahatiState lab | Jan 2023 |
| KOOCAL-500 (Calcium with Vitamin D Tablets IP) | TG21-2550Mfg 2021-10 · Exp 2023-03 | Assay of Vitamin D3Assay | RDTL GuwahatiState lab | Jan 2023 |
| KOOCAL-500 Tablets (Calcium with Vitamin D Tablets IP) | TG21-2346Mfg 2021-09 · Exp 2023-02 | Identification and Assay of ?Vitamin D3?Assay | RDTL GuwahatiState lab | Dec 2022 |
| KOOCAL-500 Tablets (Calcium with Vitamin D Tablets IP) | TG21-2565Mfg 2021-10 · Exp 2023-03 | Assay of ?Vitamin D3?Assay | RDTL GuwahatiState lab | Dec 2022 |
| Calcium with Vitamin D Tablets IP KOOCAL-500 | TG21-2539Mfg 2021-10 · Exp 2023-03 | ?Identification and Assay/Content of Vitamin D3?Assay | RDTL GuwahatiState lab | Dec 2022 |
| Calcium with Vitamin D Tablets IP KOOCAL-500 | TG21-2564Mfg 2021-10 · Exp 2023-03 | ?Identification and Assay of Vitamin D3?Assay | RDTL GuwahatiState lab | Dec 2022 |
| KOOCAL-500 (Calcium with Vitamin D Tablets IP) | TG21-2549Mfg 2021-10 · Exp 2023-03 | Identification and Assay of Vitamin D3Assay | RDTL GuwahatiState lab | Sep 2022 |
| Cefixime Dispersible Tablets (Micfox-100 Dt Tablets) | FBT19-186BMfg 2019-06 · Exp 2021-05 | AssayAssay | RDTL ChandigarhState lab | Aug 2020 |
| Telmisartan Tablets I.P. 20 mg. (Ezisartan 20) | VT17-4089Mfg 2017-11 · Exp 2019-10 | DissolutionDissolution | RDTL GuwahatiState lab | May 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.